Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients. Morales-Ortega A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al. J Infect 2021 Aug 23. pii: S0163-4453(21)00436.

Read + Share

Amedeo Smart

Independent Medical Education

Morales-Ortega A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients. J Infect 2021 Aug 23. pii: S0163-4453(21)00436.
PMID: 34437930